{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:13:57Z","timestamp":1791947637131,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RG-2405-43091"],"award-info":[{"award-number":["RG-2405-43091"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023015","name":"Advanced Research Projects Agency for Health","doi-asserted-by":"publisher","award":["75N99223S0001"],"award-info":[{"award-number":["75N99223S0001"]}],"id":[{"id":"10.13039\/100023015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["1 R01 AI131624-01A1"],"award-info":[{"award-number":["1 R01 AI131624-01A1"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["FAN-2107-38301"],"award-info":[{"award-number":["FAN-2107-38301"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.coi.2025.102647","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T16:26:44Z","timestamp":1756139204000},"page":"102647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["B-cell antigen presentation in central nervous system autoimmunity"],"prefix":"10.1016","volume":"96","author":[{"given":"Carson E","family":"Moseley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Joseph J","family":"Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2720-9915","authenticated-orcid":false,"given":"Scott S","family":"Zamvil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102647_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbadis.2010.07.020","article-title":"MS and the B cell controversy","volume":"1812","author":"Cross","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.coi.2025.102647_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.coi.2025.102647_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing\u2013remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102647_bib4","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/WNL.0b013e3181e24373","article-title":"Rituximab add-on therapy for breakthrough relapsing multiple sclerosis","volume":"74","author":"Naismith","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.coi.2025.102647_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102647_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMcibr2032177","article-title":"Antigen presentation by B cells in multiple sclerosis","volume":"384","author":"Zamvil","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102647_bib7","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200275","article-title":"MOG CNS autoimmunity and MOGAD","volume":"11","author":"Moseley","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102647_sbref8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coi.2025.102647_sbref9","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165373","article-title":"MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity","volume":"8","author":"Yandamuri","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2025.102647_bib10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S1474-4422(24)00077-2","article-title":"Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial","volume":"23","author":"Cree","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coi.2025.102647_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jnnp-2024-333464","article-title":"Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"96","author":"Virupakshaiah","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.coi.2025.102647_bib12","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1002\/acn3.52171","article-title":"B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity","volume":"11","author":"Bennett","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.coi.2025.102647_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.0105-2896.2005.00310.x","article-title":"The lysosomal cysteine proteases in MHC class II antigen presentation","volume":"207","author":"Hsing","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2025.102647_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10281","article-title":"Stepwise B-cell-dependent expansion of T helper clonotypes diversifies the T-cell response","volume":"7","author":"Merkenschlager","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2025.102647_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","article-title":"Antigen-specific interaction between T and B cells","volume":"314","author":"Lanzavecchia","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102647_bib16","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2","article-title":"B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide","volume":"29","author":"Lyons","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2025.102647_bib17","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC class II\u2013dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102647_bib18","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102647_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell\u2013mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102647_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","article-title":"Memory B cells activate brain-homing, autoreactive CD4+ T cells in multiple sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.coi.2025.102647_bib21","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","article-title":"HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coi.2025.102647_sbref22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416097121","article-title":"CD4 T cells restricted to DRB1*15:01 recognize two Epstein\u2013Barr virus glycoproteins capable of intracellular antigen presentation","volume":"121","author":"Drosu","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102647_sbref23","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221322","article-title":"Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease","volume":"220","author":"Steinman","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102647_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102647_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-020-03075-w","article-title":"Mechanism of EBV inducing anti-tumour immunity and its therapeutic use","volume":"590","author":"Choi","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102647_sbref26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41586-024-07079-8","article-title":"B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4","volume":"627","author":"Afzali","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102647_sbref27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2306572120","article-title":"T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity","volume":"120","author":"Sagan","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102647_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-025-01947-8","article-title":"AQP4-specific T cells determine lesion localization in the CNS in a model of NMOSD","volume":"13","author":"Afzali","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.coi.2025.102647_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41577-024-01076-8","article-title":"Antigen presentation for central tolerance induction","volume":"25","author":"Klein","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2025.102647_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-021-03187-x","article-title":"Dynamic regulation of TFH selection during the germinal centre reaction","volume":"591","author":"Merkenschlager","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102647_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2024.113764","article-title":"High-yield production of recombinant human myelin oligodendrocyte glycoprotein in SHuffle bacteria without a refolding step","volume":"534","author":"Wu","year":"2024","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.coi.2025.102647_bib32","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/brain\/awad373","article-title":"Interferon-\u03b3 controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorder","volume":"147","author":"Arellano","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102647_bib33","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.2200721","article-title":"Proteolipid protein\u2013induced mouse model of multiple sclerosis requires B cell\u2013mediated antigen presentation","volume":"211","author":"Wilhelm","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2025.102647_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1209749","article-title":"Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders","volume":"14","author":"Takai","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.coi.2025.102647_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/82717","article-title":"Reciprocal regulation of polarized cytokine production by effector B and T cells","volume":"1","author":"Harris","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2025.102647_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF\u2013producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2025.102647_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102647_bib38","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1901747","article-title":"Trial of satralizumab in neuromyelitis optica spectrum disorder","volume":"381","author":"Yamamura","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102647_bib39","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102647_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4\u2013specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102647_bib41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/13524585241254731","article-title":"Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody\u2013associated disease","volume":"30","author":"Uzawa","year":"2024","journal-title":"Mult Scler J"},{"key":"10.1016\/j.coi.2025.102647_bib42","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200243","article-title":"Life-threatening MOG antibody-associated hemorrhagic ADEM with elevated CSF IL-6","volume":"11","author":"Virupakshaiah","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102647_bib43","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200150","article-title":"Dramatic response to anti-IL-6 receptor therapy in children with life-threatening myelin oligodendrocyte glycoprotein-associated disease","volume":"10","author":"McLendon","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102647_bib44","article-title":"Interleukin-6 receptor blockade in treatment-refractory MOG-IgG\u2013associated disease and neuromyelitis optica spectrum disorders","volume":"9","author":"Ringelstein","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102647_sbref45","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.immuni.2024.08.005","article-title":"Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases","volume":"57","author":"Saggau","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2025.102647_bib46","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.immuni.2024.09.005","article-title":"An autoreactive T cell\u2019s perception of a land of plenty","volume":"57","author":"Korn","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2025.102647_bib47","first-page":"1132","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA\u00a0Neurol"},{"key":"10.1016\/j.coi.2025.102647_bib48","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102647_bib49","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102647_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105093","article-title":"Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis","volume":"80","author":"Molazadeh","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.coi.2025.102647_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adn2784","article-title":"T\u2013B cell cooperation in ectopic lymphoid follicles propagates CNS autoimmunity","volume":"10","author":"Kolz","year":"2025","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2025.102647_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49259-0","article-title":"Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner","volume":"15","author":"Fazazi","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2025.102647_bib53","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa2415988","article-title":"Tolebrutinib in nonrelapsing secondary progressive multiple sclerosis","volume":"392","author":"Fox","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102647_bib54","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/jimmun\/vkaf008","article-title":"Can autoimmune disease be cured by deep CD19+ cell depletion?","volume":"214","author":"Suan","year":"2025","journal-title":"J Immunol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:26:32Z","timestamp":1772825192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525001232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":54,"alternative-id":["S0952791525001232"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102647","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-cell antigen presentation in central nervous system autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102647"}}